Cargando…
Clinical implications of a novel prognostic factor AIFM3 in breast cancer patients
BACKGROUND: In a time of increasing concerns over personalized and precision treatment in breast cancer (BC), filtering prognostic factors attracts more attention. Apoptosis-Inducing Factor Mitochondrion-associated 3 (AIFM3) is widely expressed in various tissues and aberrantly expressed in several...
Autores principales: | Zheng, Ang, Zhang, Lin, Song, Xinyue, Wang, Yuying, Wei, Minjie, Jin, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518782/ https://www.ncbi.nlm.nih.gov/pubmed/31088422 http://dx.doi.org/10.1186/s12885-019-5659-4 |
Ejemplares similares
-
Apoptosis-Inducing Factor, Mitochondrion-Associated 3 (AIFM3) Protein Level in the Sera as a Prognostic Marker of Cholangiocarcinoma Patients
por: Chua-on, Daraporn, et al.
Publicado: (2020) -
Expanding the spectrum of neonatal‐onset AIFM1‐associated disorders
por: Zambon, Alberto A., et al.
Publicado: (2023) -
AIFM1 beyond cell death: An overview of this OXPHOS-inducing factor in mitochondrial diseases
por: Wischhof, Lena, et al.
Publicado: (2022) -
Long non-coding RNA LUCAT1/miR-5582-3p/TCF7L2 axis regulates breast cancer stemness via Wnt/β-catenin pathway
por: Zheng, Ang, et al.
Publicado: (2019) -
Identification of a novel AIFM1 variant from a Chinese family with auditory neuropathy
por: Wang, Rongrong, et al.
Publicado: (2022)